Estimated median (95% CI) CD4 cell count by HIV-1 subtype and time since cART initiation.

Rate of CD4+ cell count increase over periods of viral load suppression: relationship with the number of previous virological failures

Trotta, MP
Cozzi Lepri, A
Ammassari, A
Vecchiet, J
Cassola, G
Caramello, P
Vullo, V
Soscia, F
Chiodera, A
Ladisa, N
Abeli, C
Cauda, R
Buonuomi, AR
Antinori, A
d'Arminio Monforte, A
PERNO, CARLO FEDERICO

August 2010

Although the kinetics of CD4(+) cell counts have been extensively studied in antiretroviral-naive HI...

CD4(+) cell dynamics in untreated HIV-1 infection: overall rates, and effects of age, viral load, sex and calendar time

Cori, Anne
Pickles, Michael
van Sighem, Ard
Gras, Luuk
Bezemer, Daniela
Reiss, Peter
Fraser, Christophe

January 2015

Background:CD4(+) cell count is a key measure of HIV disease progression, and the basis of successiv...

Unstratified and stratified observed and weighted median (interquartile range) CD4+ cell counts for years 1, 4, 7 and 10 after start of antiretroviral therapy and the percentage of patients with weighted CD4+ cell count >500/μL at year 10.

Paula M. Luz (155841)
Beatriz Grinsztejn (116216)
Luciane Velasque (353931)
Antonio G. Pacheco (376785)
Valdilea G. Veloso (2833304)
Richard D. Moore (340677)
Claudio J. Struchiner (238880)

April 2014

HIV: human immunodeficiency virus, ART: antiretroviral therapy, ADI: AIDS defining illness.a<...

Observed (A) and predicted (B) CD4 cell count by HIV-1 subtype.

Giota Touloumi (71587)
Nikos Pantazis (330441)
Marie-Laure Chaix (204736)
Heiner C. Bucher (134728)
Robert Zangerle (288358)
Anne-Marte Bakken Kran (439586)
Rodolphe Thiebaut (199634)
Bernard Masquelier (249757)
Claudia Kucherer (5655811)
Antonella d'Arminio Monforte (182235)
Laurence Meyer (130347)
Kholoud Porter (252703)

July 2013

A: Median profiles (numbers on top indicate individuals contributing measurements at each time po...

Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs

Anderegg, Nanina
Panayidou, Klea
Abo, Yao
Alejos, Belen
Althoff, Keri N.
Anastos, Kathryn
Antinori, Andrea
Balestre, Eric
Becquet, Renaud
Castagna, Antonella
Castelnuovo, Barbara
Chêne, Geneviève
Coelho, Lara
Collins, Intira Jeannie
Costagliola, Dominique
Crabtree-Ramírez, Brenda
Dabis, Francois
D'Arminio Monforte, Antonella
Davies, Mary-Ann
de Wit, Stéphane
Delpech, Valérie
de La Mata, Nicole L.
Duda, Stephany
Freeman, Aimee
Gange, Stephen J.
Grabmeier-Pfistershammer, Katharina
Gunsenheimer-Bartmeyer, Barbara
Jiamsakul, Awachana
Kitahata, Mari M.
Law, Matthew
Manzardo, Christian
McGowan, Catherine
Meyer, Laurence
Moore, Richard
Mussini, Cristina
Nakigoz, Gertrude
Nash, Denis
tek Ng, Oon
Obel, Niels
Pantazis, Nikos
Poda, Armel
Raben, Dorthe
Reiss, Peter
Riggen, Larry
Sabin, Caroline
d'Amour Sinayobye, Jean
Sönnerborg, Anders
Stoeckle, Marcel
Thorne, Claire
Torti, Carlo

January 2018

Early initiation of combination antiretroviral therapy (cART), at higher CD4 cell counts, prevents d...

Longitudinal analyses of CD4:CD8 ratio in CMV+ and CMV- HIV-infected patients on first-line cART.

Isabelle Poizot-Martin (78137)
Clotilde Allavena (412375)
Claudine Duvivier (412376)
Carla Eliana Cano (3337224)
Francine Guillouet de Salvador (3337221)
David Rey (697350)
Pierre Dellamonica (107617)
Lise Cuzin (78139)
Antoine Cheret (3337227)
Bruno Hoen (746723)

November 2016

Data are shown for all study participants (a and c) or patients achieving CD4+ cell counts ≥500/m...

Virologic and immunologic response to cART by HIV-1 subtype in the CASCADE collaboration.

Giota Touloumi
Nikos Pantazis
Marie-Laure Chaix
Heiner C Bucher
Robert Zangerle
Anne-Marte Bakken Kran
Rodolphe Thiebaut
Bernard Masquelier
Claudia Kucherer
Antonella d'Arminio Monforte
Laurence Meyer
Kholoud Porter

We aimed to compare rates of virologic response and CD4 changes after combination antiretroviral (cA...

Virologic and Immunologic Response to cART by HIV-1 Subtype in the CASCADE Collaboration

Touloumi Giota
Pantazis Nikos
Chaix Marie-Laure
Bucher Heiner C.
Zangerle Robert
Kran Anne-Marte Bakken
Thiebaut Rodolphe
Masquelier Bernard
Kucherer Claudia
Monforte Antonella d'Arminio
Meyer Laurence
Porter Kholoud

July 2013

We aimed to compare rates of virologic response and CD4 changes after combination antiretroviral (cA...

Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversion

Stirrup, O. T.
Copas, A. J.
Phillips, A. N.
Gill, M. J.
Geskus, R. B.
Touloumi, G.
Young, J.
Bucher, H. C.
Babiker, A. G.

January 2018

To investigate factors that predict speed of recovery and long-term CD4 cell count in HIV-1 seroconv...

Median baseline CD4 cell counts (within 6 months of diagnosis) of newly diagnosed HIV individuals in China from 2006 to 2012, stratified by age group.

Houlin Tang (573087)
Yurong Mao (573088)
Cynthia X. Shi (521405)
Jing Han (43038)
Liyan Wang (569076)
Juan Xu (225010)
Qianqian Qin (202246)
Roger Detels (255434)
Zunyou Wu (283433)

June 2014

The median baseline CD4 cell counts, stratified by age group, increased each year from 2006 to 20...

Differences in CD4 cell counts at seroconversion and decline among 5739 HIV-1-infected individuals with well-estimated dates of seroconversion.

CASCADE Collaboration

January 2003

We studied repeated measurements of CD4 cell counts on 5739 HIV-1-infected individuals with reliably...

Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements

antiretroviral therapy cohort collaboration
E. Lanoy
M. May
A. Mocroft
A. Phillip
A. Justice
G. Chêne
H. Furrer
T. Sterling
L. Force
J. Gill
R. Harris
R. S. Hogg
J. Rockstroh
M. Saag
P. Khaykin
F. de Wolf
J. A. Sterne
D. Costagliola
A. D'Arminio Monforte

January 2009

CD4 cell count and plasma viral load are well known predictors of AIDS and mortality in HIV-1-infect...

Median CD4 count (cells/µl) and interquartile range, from ART initiation in the HIV-2 cohort, IeDEA West Africa collaboration.

Didier K. Ekouevi (127416)
Eric Balestre (199601)
Patrick A. Coffie (530427)
Daouda Minta (587065)
Eugene Messou (3697207)
Adrien Sawadogo (587066)
Albert Minga (330446)
Papa Salif Sow (135540)
Emmanuel Bissagnene (127445)
Serge P. Eholie (127440)
Geoffrey S. Gottlieb (235246)
François Dabis (78475)

June 2013

Median CD4 count (cells/µl) and interquartile range, from ART initiation in the HIV-2 cohort, IeD...

Role of HIV infection duration and CD4 cell level at initiation of combination anti-retroviral therapy on risk of failure.

Sara Lodi
Andrew Phillips
Sarah Fidler
David Hawkins
Richard Gilson
Ken McLean
Martin Fisher
Frank Post
Anne M Johnson
Louise Walker-Nthenda
David Dunn
Kholoud Porter

The development of HIV drug resistance and subsequent virological failure are often cited as potenti...

Univariate and multivariate Hazard Ratios (HRs) for cART initiation according to geographic origin, gender and HIV transmission group in baseline CD4 cell count strata (Cox model).

Laure-Amélie de Monteynard (697346)
Rosemary Dray-Spira (150386)
Pierre de Truchis (323395)
Sophie Grabar (697347)
Odile Launay (78130)
Jean-Luc Meynard (213429)
Marie-Aude Khuong-Josses (697348)
Jacques Gilquin (697349)
David Rey (697350)
Anne Simon (198151)
Juliette Pavie (363237)
Aba Mahamat (181770)
Sophie Matheron (361188)
Dominique Costagliola (131086)
Sophie Abgrall (697351)

March 2015

* HR adjusted for age at enrolment, enrolment period, region of care, pVL at enrolment, and hepat...

Rate of CD4+ cell count increase over periods of viral load suppression: relationship with the number of previous virological failures

Trotta, MP
Cozzi Lepri, A
Ammassari, A
Vecchiet, J
Cassola, G
Caramello, P
Vullo, V
Soscia, F
Chiodera, A
Ladisa, N
Abeli, C
Cauda, R
Buonuomi, AR
Antinori, A
d'Arminio Monforte, A
PERNO, CARLO FEDERICO

August 2010

Although the kinetics of CD4(+) cell counts have been extensively studied in antiretroviral-naive HI...

CD4(+) cell dynamics in untreated HIV-1 infection: overall rates, and effects of age, viral load, sex and calendar time

Cori, Anne
Pickles, Michael
van Sighem, Ard
Gras, Luuk
Bezemer, Daniela
Reiss, Peter
Fraser, Christophe

January 2015

Background:CD4(+) cell count is a key measure of HIV disease progression, and the basis of successiv...

Unstratified and stratified observed and weighted median (interquartile range) CD4+ cell counts for years 1, 4, 7 and 10 after start of antiretroviral therapy and the percentage of patients with weighted CD4+ cell count >500/μL at year 10.

Paula M. Luz (155841)
Beatriz Grinsztejn (116216)
Luciane Velasque (353931)
Antonio G. Pacheco (376785)
Valdilea G. Veloso (2833304)
Richard D. Moore (340677)
Claudio J. Struchiner (238880)

April 2014

HIV: human immunodeficiency virus, ART: antiretroviral therapy, ADI: AIDS defining illness.a<...

Observed (A) and predicted (B) CD4 cell count by HIV-1 subtype.

Giota Touloumi (71587)
Nikos Pantazis (330441)
Marie-Laure Chaix (204736)
Heiner C. Bucher (134728)
Robert Zangerle (288358)
Anne-Marte Bakken Kran (439586)
Rodolphe Thiebaut (199634)
Bernard Masquelier (249757)
Claudia Kucherer (5655811)
Antonella d'Arminio Monforte (182235)
Laurence Meyer (130347)
Kholoud Porter (252703)

July 2013

A: Median profiles (numbers on top indicate individuals contributing measurements at each time po...

Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs

Anderegg, Nanina
Panayidou, Klea
Abo, Yao
Alejos, Belen
Althoff, Keri N.
Anastos, Kathryn
Antinori, Andrea
Balestre, Eric
Becquet, Renaud
Castagna, Antonella
Castelnuovo, Barbara
Chêne, Geneviève
Coelho, Lara
Collins, Intira Jeannie
Costagliola, Dominique
Crabtree-Ramírez, Brenda
Dabis, Francois
D'Arminio Monforte, Antonella
Davies, Mary-Ann
de Wit, Stéphane
Delpech, Valérie
de La Mata, Nicole L.
Duda, Stephany
Freeman, Aimee
Gange, Stephen J.
Grabmeier-Pfistershammer, Katharina
Gunsenheimer-Bartmeyer, Barbara
Jiamsakul, Awachana
Kitahata, Mari M.
Law, Matthew
Manzardo, Christian
McGowan, Catherine
Meyer, Laurence
Moore, Richard
Mussini, Cristina
Nakigoz, Gertrude
Nash, Denis
tek Ng, Oon
Obel, Niels
Pantazis, Nikos
Poda, Armel
Raben, Dorthe
Reiss, Peter
Riggen, Larry
Sabin, Caroline
d'Amour Sinayobye, Jean
Sönnerborg, Anders
Stoeckle, Marcel
Thorne, Claire
Torti, Carlo

January 2018

Early initiation of combination antiretroviral therapy (cART), at higher CD4 cell counts, prevents d...

Longitudinal analyses of CD4:CD8 ratio in CMV+ and CMV- HIV-infected patients on first-line cART.

Isabelle Poizot-Martin (78137)
Clotilde Allavena (412375)
Claudine Duvivier (412376)
Carla Eliana Cano (3337224)
Francine Guillouet de Salvador (3337221)
David Rey (697350)
Pierre Dellamonica (107617)
Lise Cuzin (78139)
Antoine Cheret (3337227)
Bruno Hoen (746723)

November 2016

Data are shown for all study participants (a and c) or patients achieving CD4+ cell counts ≥500/m...

Virologic and immunologic response to cART by HIV-1 subtype in the CASCADE collaboration.

Giota Touloumi
Nikos Pantazis
Marie-Laure Chaix
Heiner C Bucher
Robert Zangerle
Anne-Marte Bakken Kran
Rodolphe Thiebaut
Bernard Masquelier
Claudia Kucherer
Antonella d'Arminio Monforte
Laurence Meyer
Kholoud Porter

We aimed to compare rates of virologic response and CD4 changes after combination antiretroviral (cA...

Virologic and Immunologic Response to cART by HIV-1 Subtype in the CASCADE Collaboration

Touloumi Giota
Pantazis Nikos
Chaix Marie-Laure
Bucher Heiner C.
Zangerle Robert
Kran Anne-Marte Bakken
Thiebaut Rodolphe
Masquelier Bernard
Kucherer Claudia
Monforte Antonella d'Arminio
Meyer Laurence
Porter Kholoud

July 2013

We aimed to compare rates of virologic response and CD4 changes after combination antiretroviral (cA...

Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversion

Stirrup, O. T.
Copas, A. J.
Phillips, A. N.
Gill, M. J.
Geskus, R. B.
Touloumi, G.
Young, J.
Bucher, H. C.
Babiker, A. G.

January 2018

To investigate factors that predict speed of recovery and long-term CD4 cell count in HIV-1 seroconv...

Median baseline CD4 cell counts (within 6 months of diagnosis) of newly diagnosed HIV individuals in China from 2006 to 2012, stratified by age group.

Houlin Tang (573087)
Yurong Mao (573088)
Cynthia X. Shi (521405)
Jing Han (43038)
Liyan Wang (569076)
Juan Xu (225010)
Qianqian Qin (202246)
Roger Detels (255434)
Zunyou Wu (283433)

June 2014

The median baseline CD4 cell counts, stratified by age group, increased each year from 2006 to 20...

Differences in CD4 cell counts at seroconversion and decline among 5739 HIV-1-infected individuals with well-estimated dates of seroconversion.

CASCADE Collaboration

January 2003

We studied repeated measurements of CD4 cell counts on 5739 HIV-1-infected individuals with reliably...

Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements

antiretroviral therapy cohort collaboration
E. Lanoy
M. May
A. Mocroft
A. Phillip
A. Justice
G. Chêne
H. Furrer
T. Sterling
L. Force
J. Gill
R. Harris
R. S. Hogg
J. Rockstroh
M. Saag
P. Khaykin
F. de Wolf
J. A. Sterne
D. Costagliola
A. D'Arminio Monforte

January 2009

CD4 cell count and plasma viral load are well known predictors of AIDS and mortality in HIV-1-infect...

Median CD4 count (cells/µl) and interquartile range, from ART initiation in the HIV-2 cohort, IeDEA West Africa collaboration.

Didier K. Ekouevi (127416)
Eric Balestre (199601)
Patrick A. Coffie (530427)
Daouda Minta (587065)
Eugene Messou (3697207)
Adrien Sawadogo (587066)
Albert Minga (330446)
Papa Salif Sow (135540)
Emmanuel Bissagnene (127445)
Serge P. Eholie (127440)
Geoffrey S. Gottlieb (235246)
François Dabis (78475)

June 2013

Median CD4 count (cells/µl) and interquartile range, from ART initiation in the HIV-2 cohort, IeD...

Role of HIV infection duration and CD4 cell level at initiation of combination anti-retroviral therapy on risk of failure.

Sara Lodi
Andrew Phillips
Sarah Fidler
David Hawkins
Richard Gilson
Ken McLean
Martin Fisher
Frank Post
Anne M Johnson
Louise Walker-Nthenda
David Dunn
Kholoud Porter

The development of HIV drug resistance and subsequent virological failure are often cited as potenti...

Univariate and multivariate Hazard Ratios (HRs) for cART initiation according to geographic origin, gender and HIV transmission group in baseline CD4 cell count strata (Cox model).

Laure-Amélie de Monteynard (697346)
Rosemary Dray-Spira (150386)
Pierre de Truchis (323395)
Sophie Grabar (697347)
Odile Launay (78130)
Jean-Luc Meynard (213429)
Marie-Aude Khuong-Josses (697348)
Jacques Gilquin (697349)
David Rey (697350)
Anne Simon (198151)
Juliette Pavie (363237)
Aba Mahamat (181770)
Sophie Matheron (361188)
Dominique Costagliola (131086)
Sophie Abgrall (697351)

March 2015

* HR adjusted for age at enrolment, enrolment period, region of care, pVL at enrolment, and hepat...

Rate of CD4+ cell count increase over periods of viral load suppression: relationship with the number of previous virological failures

Trotta, MP
Cozzi Lepri, A
Ammassari, A
Vecchiet, J
Cassola, G
Caramello, P
Vullo, V
Soscia, F
Chiodera, A
Ladisa, N
Abeli, C
Cauda, R
Buonuomi, AR
Antinori, A
d'Arminio Monforte, A
PERNO, CARLO FEDERICO

August 2010

Although the kinetics of CD4(+) cell counts have been extensively studied in antiretroviral-naive HI...

CD4(+) cell dynamics in untreated HIV-1 infection: overall rates, and effects of age, viral load, sex and calendar time

Cori, Anne
Pickles, Michael
van Sighem, Ard
Gras, Luuk
Bezemer, Daniela
Reiss, Peter
Fraser, Christophe

January 2015

Background:CD4(+) cell count is a key measure of HIV disease progression, and the basis of successiv...

Unstratified and stratified observed and weighted median (interquartile range) CD4+ cell counts for years 1, 4, 7 and 10 after start of antiretroviral therapy and the percentage of patients with weighted CD4+ cell count >500/μL at year 10.

Paula M. Luz (155841)
Beatriz Grinsztejn (116216)
Luciane Velasque (353931)
Antonio G. Pacheco (376785)
Valdilea G. Veloso (2833304)
Richard D. Moore (340677)
Claudio J. Struchiner (238880)

April 2014

HIV: human immunodeficiency virus, ART: antiretroviral therapy, ADI: AIDS defining illness.a<...

Estimated median (95% CI) CD4 cell count by HIV-1 subtype and time since cART initiation.

Abstract

Extracted data

Estimated median (95% CI) CD4 cell count by HIV-1 subtype and time since cART initiation.

Abstract

Extracted data

Related items

Related items